Genetic heterogeneity in pbp genes among clinically isolated group B streptococci with reduced penicillin susceptibility

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 12, 2008, Pages 4258-4267

  Nagano, Noriyuki ^a,b   Nagano, Yukiko ^a   Kimura, Kouji ^a   Tamai, Kiyoko ^a,c   Yanagisawa, Hideji ^c   Arakawa, Yoshichika ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b Funabashi Municipal Medical Center   (Japan)

^c Miroku Medical Laboratory Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFAZOLIN; CEFDITOREN; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFOTIAM; CEFOZOPRAN; CEFTAZIDIME; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 1A; PENICILLIN BINDING PROTEIN 1B; PENICILLIN BINDING PROTEIN 2A; PENICILLIN BINDING PROTEIN 2B; PENICILLIN BINDING PROTEIN 2X; PENICILLIN G; TETRACYCLINE; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COMPARATIVE GENE MAPPING; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC LINE; GENETIC TRANSCRIPTION; HUMAN; INFANT; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR PHYLOGENY; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PENICILLIN BINDING PROTEIN 1A GENE; PENICILLIN BINDING PROTEIN 1B GENE; PENICILLIN BINDING PROTEIN 2A GENE; PENICILLIN BINDING PROTEIN 2B GENE; PENICILLIN BINDING PROTEIN 2X GENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; SEQUENCE ANALYSIS; STREPTOCOCCUS AGALACTIAE;

AMINOACYLTRANSFERASES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; FEMALE; GENETIC HETEROGENEITY; HUMANS; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PENICILLIN RESISTANCE; PENICILLIN-BINDING PROTEINS; PENICILLINS; PHYLOGENY; SEQUENCE ANALYSIS, DNA; STREPTOCOCCUS AGALACTIAE;

EID: 57049109468     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00596-08     Document Type: Article

References (40)

1. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
2. Appelbaum, P. C., A. Bhamjee, J. N. Scragg, A. F. Hallett, A. J. Bowen, and R. C. Cooper. 1977. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet ii:995-997.
3. Biedenbach, D. J., J. M. Stephen, and R. N. Jones. 2003. Antimicrobial susceptibility profile among beta-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program - North America, 2001. Diagn. Microbiol. Infect. Dis. 46:291-294.
4. Clinical and Laboratory Standards Institute. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6, 6th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing. Supplement M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Dahesh, S., M. E. Hensler, N. M. Van Sorge, R. E. Gertz, Jr., S. Schrag, V. Nizet, and B. W. Beall. 2008. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to β-lactam antibiotics. Antimicrob. Agents Chemother. 52:2915-2918.
7. De Azavedo, J. C., M. McGavin, C. Duncan, D. E. Low, and A. McGeer. 2001. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob. Agents Chemother. 45:3504-3508.
8. Farley, M. M., R. C. Harvey, T. Stull, J. D. Smith, A. Schuchat, J. D. Wenger, and D. S. Stephens. 1993. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N. Engl. J. Med. 328:1807-1811.
9. Fernandez, M., M. E. Hickman, and C. J. Baker. 1998. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob. Agents Chemother. 42:1517-1519.
10. Goffin, C., and J. M. Ghuysen. 1998. Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs. Microbiol. Mol. Biol. Rev. 62:1079-1093.
11. Graham, M. R., L. M. Smoot, C. A. Migliaccio, K. Virtaneva, D. E. Sturdevant, S. F. Porcella, M. J. Federle, G. J. Adams, J. R. Scott, and J. M. Musser. 2002. Virulence control in group A streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc. Natl. Acad. Sci. USA 99:13855-13860.
12. Grebe, T., and R. Hakenbeck. 1996. Penicillin-binding proteins 2B and 2X of Streptococcus pneumoniae are primary resistance determinants for different classes of beta-lactam antibiotics. Antimicrob. Agents Chemother. 40:829-834.
13. Hansman, D., and M. M. Bullen. 1967. A resistant pneumococcus. Lancet ii:264-265.
14. Heelan, J. S., M. E. Hasenbein, and A. J. McAdam. 2004. Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin. J. Clin. Microbiol. 42:1263-1264.
15. Horne, D., and A. Tomasz. 1981. pH-dependent penicillin tolerance of group B streptococci. Antimicrob. Agents Chemother. 20:128-135.
16. Hsueh, P.-R., L.-J. Teng, L.-N. Lee, S.-W. Ho, P.-C. Yang, and K.-T. Luh. 2001. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob. Agents Chemother. 45:3205-3208.
17. Jones, A. L., R. H. Needham, A. Clancy, K. M. Knol, and C. E. Rubens. 2003. Penicillin-binding proteins in Streptococcus agalactiae: a novel mechanism for evasion of immune clearance. Mol. Microbiol. 47:247-256.
18. Kawamura, Y., H. Fujiwara, N. Mishima, Y. Tanaka, A. Tanimoto, S. Ikawa, Y. Itoh, and T. Ezaki. 2003. First Streptococcus agalactiae isolates highly resistant to quinolones with point mutations in gyrA and parC. Antimicrob. Agents Chemother. 47:3605-3609.
19. Kimura, K., S. Suzuki, J. Wachino, H. Kurokawa, K. Yamane, N. Shibata, N. Nagano, H. Kato, K. Shibayama, and Y. Arakawa. 2008. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother. 52:2890-2897.
20. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3:171-196.
21. Kumar, S., K. Tamura, and M. Nei. 2004. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief. Bioinform. 5:150-163.
22. Morikawa, Y., M. Kitazato, C. Katsukawa, and A. Tamaru. 2003. Prevalence of cefotaxime resistance in group B streptococcus isolates from Osaka, Japan. J. Infect. Chemother. 9:131-133.
23. Munoz, R., C. G. Dowson, M. Daniels, T. J. Coffey, C. Martin, R. Hakenbeck, and B. G. Spratt. 1992. Genetics of resistance to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae. Mol. Microbiol. 6:2461-2465.
24. Murdoch, D. R., and L. B. Reller. 2001. Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10 year perspective. Antimicrob. Agents Chemother. 45:3623-3624.
25. Nagano, N., N. Shibata, Y. Saitou, Y. Nagano, and Y. Arakawa. 2003. Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type β-lactamase. J. Clin. Microbiol. 41:5530-5536.
26. Nagano, N., Y. Nagano, and F. Taguchi. 2002. High expression of a C protein β antigen gene among invasive strains from certain clonally related groups of type Ia and Ib group B streptococci. Infect. Immun. 70:4643-4649.
27. Nagano, N., Y. Nagano, R. Nakano, R. Okamoto, and M. Inoue. 2006. Genetic diversity of the C protein β-antigen gene and its upstream regions within clonally related groups of type Ia and Ib group B streptococci. Microbiology 152:771-778.
28. Pernot, L., L. Chesnel, A. Le Gouellec, J. Croize, T. Vernet, O. Dideberg, and A. Dessen. 2004. A PBP2x from a clinical isolate of Streptococcus pneumoniae exhibits an alternative mechanism for reduction of susceptibility to betalactam antibiotics. J. Biol. Chem. 279:16463- 16470.
29. Regan, J. A., M. A. Klebanoff, R. P. Nugent, et al. 1991. The epidemiology of group B streptococcal colonization in pregnancy. Obstet. Gynecol. 77:604-610.
30. Saez-Llorens, X., and G. H. McCracken, Jr. 2003. Bacterial meningitis in children. Lancet 361:2139-2148.
31. Schuchat, A. 1998. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev. 11:497-513.
32. Schuchat, A. 1999. Group B streptococcus. Lancet 353:51-56.
33. Smith, A. M., and K. P. Klugman. 1998. Alterations in PBP 1A essential for high-level penicillin resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:1329-1333.
34. Spratt, B. G., and K. D. Cromie. 1988. Penicillin-binding proteins of gram-negative bacteria. Rev. Infect. Dis. 10:699-711.
35. Takahashi, S., E. E. Adderson, Y. Nagano, N. Nagano, M. R. Briesacher, and J. F. Bohnsack. 1998. Identification of a highly encapsulated, genetically related group of invasive type III group B streptococci. J. Infect. Dis. 177:1116-1119.
36. Takahashi, S., Y. Nagano, N. Nagano, O. Hayashi, F. Taguchi, and Y. Okuwaki. 1995. Role of C5a-ase in group B streptococcal resistance to opsonophagocytic killing. Infect. Immun. 63:4764-4769.
37. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
38. Tunkel, A. R., B. J. Hartman, S. L. Kaplan, B. A. Kaufman, K. L. Roos, W. M. Scheld, and R. J. Whitley. 2004. Practice guidelines for the management of bacterial meningitis. Clin. Infect. Dis. 39:1267-1284.
39. van Asselt, G. J., G. de Kort, and J. A. M. van de Klundert. 1995. Differences in penicillin-binding protein patterns of penicillin tolerant and nontolerant group A streptococci. J. Antimicrob. Chemother. 35:67-74.
40. Wehbeh, W., R. Rojas-Diaz, X. Li, N. Mariano, L. Grenner, S. Segal-Maurer, B. Tommasulo, K. Drlica, C. Urban, and J. J. Rahal. 2005. Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance. Antimicrob. Agents Chemother. 49:2495-2497.